Corporate News 03-Nov-20
Board of Ajanta Pharma approves buyback of shares up to Rs 135.97 cr
At meeting held on 13 November 2020
The Board of Ajanta Pharma at its meeting held on 13 November 2020 has approved the proposal for buyback up to 7.35 lakh equity shares at a price of Rs 1850 per share for an aggregate consideration of up to Rs 135.97 crore.
Previous News
Stocks in focus: Ajanta Pharma, Zydus Lifesciences, HAL, L&T, Deccan Gold Mines
( Market Commentary - Stock Alert 08-Mar-23 08:32 )
Ajanta Pharma
( Results - Analysis 31-Oct-23 23:40 )
Ajanta Pharma consolidated net profit rises 65.82% in the March 2024 quarter
( Results - Announcements 02-May-24 16:53 )
Ajanta Pharma fixes record date for bonus issue
( Market Beat - Reports 13-Jun-22 13:07 )
Ajanta Pharma consolidated net profit rises 8.58% in the December 2021 quarter
( Results - Announcements 31-Jan-22 16:24 )
Volumes spurt at K E C International Ltd counter
( Hot Pursuit - 13-Sep-23 14:30 )
Ajanta Pharma drops after Q2 PAT slides 20% YoY to Rs 157 cr
( Hot Pursuit - 04-Nov-22 12:03 )
Ajanta Pharma to convene board meeting
( Corporate News - 11-May-20 13:28 )
Ajanta Pharma Ltd leads losers in 'A' group
( Hot Pursuit - 04-Nov-22 15:00 )
Volumes soar at Trident Ltd counter
( Hot Pursuit - 28-Jul-21 11:00 )
Ajanta Pharma announces schedule of activities for proposed buyback
( Corporate News - 26-Nov-20 12:46 )
Other Stories
Vardhan Capital & Finance schedules AGM
06-Jul-24 17:34
Automotive Axles schedules AGM
06-Jul-24 17:34
Maruti Infrastructure to conduct AGM
06-Jul-24 17:34
Torrent Power schedules AGM
06-Jul-24 17:34
Raghav Productivity Enhancers to hold AGM
06-Jul-24 17:34
Berger Paints India schedules AGM
06-Jul-24 17:33
Walpar Nutritions to conduct AGM
06-Jul-24 17:33
Weizmann AGM scheduled
06-Jul-24 17:33
Gretex Industries schedules AGM
06-Jul-24 17:33
Karma Energy schedules AGM
06-Jul-24 17:33
Back
Top
